glp-1 news 2025 november 25 Pipeline Update: August - Prime Therapeutics GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Limit use to 23 days

The results suggest that although the improvement of mouth opening was better in combination group, the difference was insignificant (Kumar et al., 2007)

Microbiome alterations, which reduce beneficial Lactobacillus and Bifidobacterium populations, leading to dysbiosis

The PolyPeptide Group, with facilities in Torrance, California, is one of the worlds largest independent contract manufacturers of therapeutic peptides

Food Chem 134:141148 Hitchcock JK, Mkwanazi N, Barnett C, Graham LM, Katz AA, Hunter R, Schfer G, Kaschula CH (2021) The garlic compound Z-ajoene, S-thiolates COX2 and STAT3 and dampens the inflammatory response in RAW264.7 macrophages

FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s